Clinical study on the intervention of Huangqin oil paste for chemotherapy phlebitis in cancer patients based on evidence-based nursing
基于循证护理的黄芩油膏干预肿瘤患者化疗性静脉炎的临床研究

摘要

目的 探究肿瘤化疗患者行基于循证护理的黄芩油膏干预的价值。方法 2024年7月-2025年7月，取我院肿瘤200例化疗患者，纳入标准：200例入选者确诊肿瘤，接受静脉化疗，周期超4个；无静脉炎相关病史；首次化疗。排除标准：对油膏基质或黄芩过敏者；凝血障碍者。以数表法随机分组，各组均100例，对照组+常规护理，观察组+常规护理+基于循证护理的黄芩油膏干预，对比组间价值。结果 观察组发生静脉炎几率较对照组低，严重程度较对照组轻，缓解时间较对照组短，疼痛评分较对照组更低（P<0.05）。组间安全性分析（P>0.05）。结论 基于循证护理的黄芩油膏干预利于肿瘤化疗患者发生化疗性静脉炎风险降低，症状程度减轻，疼痛减轻，值得借鉴。

Abstract

Objective To investigate the value of Huangqin Oil Ointment intervention based on evidence-based nursing for chemotherapy patients with tumors.
Methods From July 2024 to July 2025,200 chemotherapy patients with confirmed tumors at our hospital were enrolled, meeting inclusion criteria: 200 patients diagnosed with tumors, receiving intravenous chemotherapy for more than four cycles; no history of phlebitis-related conditions; first-time chemotherapy. Exclusion criteria: Patients allergic to ointment base or Huangqin; coagulation disorders. Randomized grouping using a number table method, with 100 cases in each group: control group + routine care, observation group + routine care + evidence-based nursing Huangqin Oil Ointment intervention, and comparison group.
Results The observation group showed lower incidence of phlebitis compared to the control group, milder severity, shorter recovery time, and reduced pain scores (P<0.05). Safety analysis between groups (P>0.05).
Conclusion   Evidence-based nursing Huangqin Oil Ointment intervention helps reduce the risk of chemotherapy-induced phlebitis in tumor patients, alleviate symptom severity, and relieve pain, making it clinically valuable.